iSpecimen (ISPC) Revenue (2020 - 2026)

iSpecimen (ISPC) has reported Revenue for 7 consecutive years, with $156009.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Revenue fell 85.25% year-over-year to $156009.0; the TTM figure through Mar 2026 stood at $1.0 million (down 87.25% YoY), while the FY2025 annual figure was $1.9 million, down 79.24% from the prior year.
• Revenue came in at $156009.0 for Q1 2026 at iSpecimen, up from $51761.0 in the prior quarter.
• The five-year high for Revenue was $3.0 million in Q4 2022, with the low at $51761.0 in Q4 2025.
• Average Revenue over 5 years is $1.9 million, with a median of $2.3 million recorded in 2022.
• Across the five-year window, Revenue jumped 76.21% in 2024 and tumbled 96.49% in 2025, its largest moves.
• Year by year, Revenue stood at $3.0 million in 2022, then dropped by 13.05% to $2.6 million in 2023, then plunged by 42.7% to $1.5 million in 2024, then sank by 96.49% to $51761.0 in 2025, then jumped by 201.4% to $156009.0 in 2026.
• According to Business Quant data, Revenue over the past three periods registered $156009.0, $51761.0, and $106592.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.